A study confirms that EVEN CHILDREN, together with adolescents are developing heart diseases after being vaccinated with the Covid-19 mRNA vaccines.

by Marica Micallef

A major new study published on the 25th of March 2022 in The Journal of Pediatrics entitled “Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis”[1] shows that 63% of CHILDREN have serious heart problems post-vaccination. So now, it is not only adults and adolescents. We also have children as young as 12 years of age. Here we go again….

The authors present the development of the cardiac magnetic resonance imaging findings in 16 individuals with myopericarditis who are 12 to 17 years old, after receiving the second dose of the Pfizer mRNA coronavirus illness 2019 vaccine. All patients experienced quick clinical recovery, but at a 3- to 8-month follow-up, several still had residual cardiac magnetic resonance imaging abnormalities.

Again, we have a study that is showing that children developed heart diseases after receiving the Covid-19 vaccines, and yet they try to mellow the seriousness of the situation down, by stating that the number of individuals studies was not big and all individuals in the study had clinical recovery. What they don’t tell you is that the number of children who developed heart diseases, and other kinds of illnesses, after being vaccinated, is much higher, with many children now also being reported in the media as dying suddenly post-vaccination.

However, this study does state that “In a cohort of adolescents with COVID-19 mRNA vaccine-related myopericarditis, a large portion have persistent LGE abnormalities, raising concerns for potential longer-term effects.

It is also written that the study has limitations because of the fact that other children and adolescents who were not admitted to seek medical care during an acute illness or who did not exhibit severe symptoms necessitating hospitalization were not recorded, and the course of their sickness may have differed. Their cardiac MRI results cannot be extrapolated to all individuals who had myopericarditis brought on by the mRNA vaccine due to incomplete cardiac MRI data on other patients.

It was also challenging for the study to forecast the timing of cardiac MRI changes over time since follow-up cardiac MRI timings varied from patient to patient. The overall number of patients reported is low, making it difficult to draw generalizations about the outcomes of vaccine-associated myopericarditis or assess the impact of different treatment approaches.

The 16 patients studied had a median age of 15 years, and were mostly male, white, and non-Hispanic, with one patient being Asian and one being American Indian. The median time to the presentation from the second Pfizer dose was of 3 days. All patients had chest pain, with the most common symptoms being fever and shortness of breath. All patients had elevated serum troponin levels, with 12 patients having had a C-reactive protein measured. Ten patients had an abnormal ECG. 14 out of the 16 patients had normal left ventricular systolic function with 2 showing mildly reduced LV systolic function with no dilation.

All the initial cardiac MRIs performed were abnormal and all showed evidence of edema, with 15 showing an LGE in a patchy subepicardial to transmural pattern with a predilection for the inferior left ventricular free wall.

In a nutshell, this study confirmed that following the coronavirus disease 2019 (COVID-19) mRNA immunization, myopericarditis has become a significant side event, especially in adolescents. Early cardiac magnetic resonance imaging (MRI) scans showed abnormalities such as edema and late gadolinium enhancement (LGE), which match Lake Louise’s criteria for noninvasively diagnosing myocarditis. LGE can signal a poor outcome in classical myocarditis.

And then, we have Moderna saying that the infant covid vaccine has succeeded in the trial.[2]  Based on the information, Moderna announced that it would soon file license requests to the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and other international regulators. So far, the FDA gave the green light.

According to CEO Stephane Bancel, the results are fantastic news for parents of children under the age of six. Considering the “fantastic results” we are seeing in this case adolescents and children as young as 12, post-vaccination, we can already conclude what will be the “fantastic results” of vaccinating children under the age of six. God help us.

It does not matter who you are and what age you have for the Globalists, in the Russian roulette game of the Covid-19 vaccination.


[1] https://www.jpeds.com/article/S0022-3476(22)00282-7/fulltext#%20

[2]https://insiderpaper.com/moderna-says-infant-covid-vaccine-succeeded-in-trial/

Leave a Reply

Your email address will not be published.